Preventing flu deaths
Researchers from Imperial College in London, England, isolated the receptor in the lungs that triggers the immune overreaction to flu. With the receptor identified, a therapy can be developed that will bind to the receptor, preventing the deadly immune response. Also, by targeting a receptor in humans rather than a particular strain of flu, therapies …